Randomized Controlled Trials in Substance Dependence and Antisocial Behavior
Research group
01.01.2022 -
Institute of Clinical Medicine, School of Medicine, Faculty of Health Sciences
Leaders
Research topics and goals:
- To find new effective pharmacological treatments for illicit drug dependence
- To study the efficacy of pharmacological treatment for psychopathy
Latest achievements:
- The results from Tiihonen et al. 2012 (Am J Psychiatry) provided the first evidence from a randomized controlled trial of an effective pharmacological treatment for polysubstance dependence.
Research methods
- Randomized controlled trials
Cooperation
Keywords
Publications
3 items-
Extended-release methylphenidate for treatment of amphetamine/metamphetamine depence: a randomized, double-blind, placebo-controlled trial
Miles SW, Sheridan J, Russell B, Kydd R, Wheeler A, Walters C, Gamble G, Hardley P, Jensen M, Kuoppasalmi K, Tuomola P, Föhr J, Kuikanmäki O, Vorma H, Salokangas R, Mikkonen A, Kallio M, Kauhanen J, Kiviniemi V, Tiihonen J, 2013, Addiction, 108, 7, 1279-86. A1 Journal article (refereed), original research -
Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial.
Tiihonen J, Krupitsky E, Verbitskaya E, Blokhina E, Mamontova O, Föhr J, Tuomola P, Kuoppasalmi K, Kiviniemi V, Zwartau E., 2012, American journal of psychiatry, 169, 531-536. A1 Journal article (refereed), original research -
A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence
Tiihonen J, Kuoppasalmi K, Föhr J, Tuomola P, Kuikanmäki O, Vorma H, Sokero P, Haukka J, Meririnne E, 2007, American journal of psychiatry, 164, 1, 160-162. A1 Journal article (refereed), original research